Diversified Trust’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,832
Closed -$450K 871
2022
Q3
$450K Buy
1,832
+738
+67% +$199K 0.02% 423
2022
Q2
$271K Buy
+1,094
New +$295K 0.01% 592
2021
Q4
Sell
-725
Closed -$236K 923
2021
Q3
$236K Buy
+725
New +$246K 0.01% 668
2016
Q3
Sell
-13,645
Closed -$1.49M 373
2016
Q2
$1.49M Sell
13,645
-2,090
-13% -$208K 0.17% 128
2016
Q1
$1.49M Buy
15,735
+545
+4% +$46K 0.16% 136
2015
Q4
$1.37M Sell
15,190
-9,505
-38% -$807K 0.15% 145
2015
Q3
$2.29M Buy
24,695
+15,595
+171% +$1.37M 0.25% 100
2015
Q2
$598K Buy
9,100
+2,855
+46% +$190K 0.06% 269
2015
Q1
$447K Buy
6,245
+975
+19% +$52.9K 0.04% 337
2014
Q4
$201K Buy
+5,270
New +$166K 0.02% 482
2013
Q4
$347K Buy
+12,965
New +$320K 0.04% 379

Other funds holding ABMD

Diversified Trust's ABMD Position: Q4 2022 in Review

Diversified Trust sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,832 shares — an estimated $450K sold.

Diversified Trust first reported a position in ABMD in Q4 2013 and held it in 11 quarters. The position peaked at $2.29M in Q3 2015. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Diversified Trust reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Diversified Trust sold 1,832 Abiomed Inc shares in Q4 2022, an estimated $450K.
  • Diversified Trust first reported a position in Abiomed Inc in Q4 2013 and held it in 11 quarters.
  • Diversified Trust's Abiomed Inc position peaked at $2.29M in Q3 2015.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Diversified Trust's 13F filing for Q4 2022, filed 17 Jan 2023.